Maleic Acid

Maleic Acid

SCHEMBL8364460

O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol

The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 1.00
▸ TP53 P04637 1/20 1.00
▸ EGLN1 Q9GZT9 1/20 1.00
▸ EGLN3 Q9H6Z9 1/20 1.00
▸ HCAR2 Q8TDS4 4/20 0.53
▸ GABRR1 P24046 2/20 0.47
▸ GABRR2 P28476 2/20 0.47
▸ BLM P54132 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ GABRR3 A8MPY1 1/20 0.47
▸ APEX1 P27695 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.45
▸ GAA P10253 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL613 1.00 — —
Fumaric Acid SCHEMBL650322 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL2046430 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL2046432 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Maleic Acid SCHEMBL20487516 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL4671405 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL1331192 1.00 — —
Fumaric Acid SCHEMBL8364461 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL623596 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2
Fumaric Acid SCHEMBL2046433 1.00 TSHR (1.00) TSHRTP53EGLN1EGLN3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108148443-B Preparation method of aqueous self-dispersion nano organic pigment powder 江南大学 2019-08-20 — — CN claimed
CN-108148443-A Preparation method of aqueous self-dispersion nano organic pigment powder 江南大学 2018-06-12 — — CN claimed
CN-102926224-A Preparation method of pigment ink for inkjet printing of non-adhesive textile UNIV JIANGNAN 2013-02-13 — — CN claimed
CN-116867786-A Novel maleates of triazolopyrazine derivatives, compositions, methods of use and methods of making the same 瑷备恩有限公司 2023-10-10 — — CN disclosed
US-11225456-B2 Process for the preparation of a mixture of chelating agents, mixture of chelating agents and methods of using them KEMIRA OYJ (FI) 2022-01-18 — — US disclosed
US-20200181063-A1 Process for the Preparation of a Mixture of Chelating Agents, Mixture of Chelating Agents and Methods of Using Them KEMIRA OYJ (FI) 2020-06-11 — — US disclosed
EP-3645508-A1 PROCESS FOR THE PREPARATION OF A MIXTURE OF CHELATING AGENTS, MIXTURE OF CHELATING AGENTS AND METHODS OF USING THEM Kemira Oyj (FI) 2020-05-06 — — EP disclosed
CN-108148443-B Preparation method of aqueous self-dispersion nano organic pigment powder 江南大学 2019-08-20 — — CN disclosed
WO-2019002685-A1 PROCESS FOR THE PREPARATION OF A MIXTURE OF CHELATING AGENTS, MIXTURE OF CHELATING AGENTS AND METHODS OF USING THEM KEMIRA OYJ (FI) 2019-01-03 — — WO disclosed
CN-108148443-A Preparation method of aqueous self-dispersion nano organic pigment powder 江南大学 2018-06-12 — — CN disclosed
US-6001946-A Curable silane-encapped compositions having improved performances WITCO CORPORATION (US) 1999-12-14 — — US disclosed
EP-0733035-A1 TRICYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1996-09-25 — — EP disclosed
WO-1995015939-A1 TRICYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1995-06-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181063-A1 Process for the Preparation of a Mixture of Chelating Agents, Mixture of Chelating Agents and Methods of Using Them HDHD5, NISCH, DNAJC5 TSHR 2475/4885TP53 4529/4885EGLN1 2899/4885
US-11225456-B2 Process for the preparation of a mixture of chelating agents, mixture of chelating agents and methods of using them HDHD5, NISCH, DNAJC5 TSHR 2475/4885TP53 4529/4885EGLN1 2899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback